Ilera Healthcare's guest appearances

Ilera Healthcare

The Green Rush is real.

Coming Out With Cannabis

Adam Levin

Rick Doblin

Andrea Brooks

Marvin Washington

Jason Mewes

Jim Belushi

Ziggy Marley

Rick Strassman

Evan Eneman

Emily Paxhia

Danny Moses

David Johnson

Abby Epstein

Ricki Lake

Aaron Smith

OwlTail

Oludare Odumosu

Dr. Oludare Odumosu,Chief Scientific Officer/EVP Pharmaceutical Division for Pennsylvania-based Ilera Healthcare, is this week’s guest on the Green Rush! Dr. Odumosu has an extensive scientific and medical background with a PhD. in biochemistry as well as having shepherded the development of pharmaceuticals through FDA approval and the marketing that occurs afterwards. A native of Nigeria, it’s worth mentioning that Dr. Odumosu is one of a growing number of African-Americans who are taking on leadership roles to shape the cannabis industry.In this week’s conversation, our hosts and Oludare touch on a number of fascinating subjects including social justice reform; Dr. Odumosu’s introduction to cannabis and why he credits the plant with saving his life; what drove him to make the jump from the world of academia to cannabis; how Dr. Odumosu’s past work developing pain meds has informed his work with cannabis; and what kind of study he would commission on cannabis if he worked at the FDA. We really enjoyed this informative and fun discussion with Dr. Odumosu and this conversation is sure to be of interest to all of our listeners interested in leanring more about the medicinal benefits of cannabis. Enjoy!   Dr. Oludare Odumosu BioDr. Odumosu brings 10 years of experience in corporate pharmaceutical business development, operations and strategic alliance management to his role as Ilera Healthcare’s Chief Scientific Officer/EVP Pharmaceutical Division. His background in biochemistry and healthcare entrepreneurship gives him unique qualifications for this role. Dr. Odumosu played a critical role in Iroko Pharmaceutical’s post-clinical development of Zorvolex Tivorbex and Vivlodex through FDA approvals and successful US market commercialization. He also managed the execution of the business development gate processes for the expansion of Iroko’s Solumatrix franchise products through ex-US licensing agreement negotiations. He received a PhD in Biochemistry and a Master’s in Public Health-Epidemiology and Biostatistics from the Loma Linda University School of Medicine and School of Public Health in Loma Linda, California; and a BS in Biology from Calvin College in Grand Rapids, Michigan. Dr. Odumosu is a World Bank Institute Certified public health professional with global healthcare translational/clinical/epidemiological research and data management experience.Links to guest’s social media: Oludare Odumosu’s Twitter: https://twitter.com/oludareodumosu  Oludare Odumosu’s LinkedIn: https://www.linkedin.com/in/oludare-odumosu-371125a/  Links and Mentions: Ilera Healthcare Website: https://www.ilerahealthcare.com Ilera HealthcareFacebook:  @Ilerahealth Ilera HealthcareTwitter:  @IleraHealthcare Ilera Healthcare Instagram:  @ilerahealthcare Show Credits:This episode was hosted by Anne Donohoe and Lewis Goldberg of KCSA Strategic Communications.Special thanks to our Producer Nick Opich and Program Director Shea Gunther at Marijuana TodayYou can learn more about how KCSA Cannabis can help your cannabiz by visiting www.kcsa-cannabis.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels:Twitter / Instagram: @KCSA_CannabisLinkedIn: https://www.linkedin.com/company/green-rush-comms/Facebook:https://www.facebook.com/KCSACannabiz/YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Dr. Oludare Odumosu,Chief Scientific Officer/EVP Pharmaceutical Division for Pennsylvania-based Ilera Healthcare, is this week’s guest on the Green Rush! Dr. Odumosu has an extensive scientific and medical background with a PhD. in biochemistry as well as having shepherded the development of pharmaceuticals through FDA approval and the marketing that occurs afterwards. A native of Nigeria, it’s worth mentioning that Dr. Odumosu is one of a growing number of African-Americans who are taking on leadership roles to shape the cannabis industry.In this week’s conversation, our hosts and Oludare touch on a number of fascinating subjects including social justice reform; Dr. Odumosu’s introduction to cannabis and why he credits the plant with saving his life; what drove him to make the jump from the world of academia to cannabis; how Dr. Odumosu’s past work developing pain meds has informed his work with cannabis; and what kind of study he would commission on cannabis if he worked at the FDA. We really enjoyed this informative and fun discussion with Dr. Odumosu and this conversation is sure to be of interest to all of our listeners interested in leanring more about the medicinal benefits of cannabis. Enjoy!   Dr. Oludare Odumosu BioDr. Odumosu brings 10 years of experience in corporate pharmaceutical business development, operations and strategic alliance management to his role as Ilera Healthcare’s Chief Scientific Officer/EVP Pharmaceutical Division. His background in biochemistry and healthcare entrepreneurship gives him unique qualifications for this role. Dr. Odumosu played a critical role in Iroko Pharmaceutical’s post-clinical development of Zorvolex Tivorbex and Vivlodex through FDA approvals and successful US market commercialization. He also managed the execution of the business development gate processes for the expansion of Iroko’s Solumatrix franchise products through ex-US licensing agreement negotiations. He received a PhD in Biochemistry and a Master’s in Public Health-Epidemiology and Biostatistics from the Loma Linda University School of Medicine and School of Public Health in Loma Linda, California; and a BS in Biology from Calvin College in Grand Rapids, Michigan. Dr. Odumosu is a World Bank Institute Certified public health professional with global healthcare translational/clinical/epidemiological research and data management experience.Links to guest’s social media:<ul> <li>Oludare Odumosu’s Twitter: <a href="https://twitter.com/oludareodumosu" rel="nofollow" target="_blank">https://twitter.com/oludareodumosu</a> </li> <li>Oludare Odumosu’s LinkedIn: <a href="https://www.linkedin.com/in/oludare-odumosu-371125a/" rel="nofollow" target="_blank">https://www.linkedin.com/in/oludare-odumosu-371125a/</a> </li> </ul>Links and Mentions:<ul> <li>Ilera Healthcare Website: <a href="https://www.ilerahealthcare.com" rel="nofollow" target="_blank">https://www.ilerahealthcare.com</a></li> <li>Ilera HealthcareFacebook:  <a href="https://www.facebook.com/Ilerahealth/" rel="nofollow" target="_blank">@Ilerahealth</a></li> <li>Ilera HealthcareTwitter:  <a href="https://twitter.com/IleraHealthcare" rel="nofollow" target="_blank">@IleraHealthcare</a></li> <li>Ilera Healthcare Instagram:  <a href="https://www.instagram.com/ilerahealthcare/" rel="nofollow" target="_blank">@ilerahealthcare</a></li> </ul>Show Credits:This episode was hosted by Anne Donohoe and Lewis Goldberg of KCSA Strategic Communications.Special thanks to our Producer Nick Opich and Program Director Shea Gunther at<a href="http://mjtodaypodcast.com/" rel="nofollow" target="_blank"> Marijuana Today</a>You can learn more about how KCSA Cannabis can help your cannabiz by visiting<a href="http://www.kcsa-cannabis.com" rel="nofollow" target="_blank"> www.kcsa-cannabis.com</a> or emailing greenrush@kcsa.com. You can also connect with us via our social channels:Twitter / Instagram: @KCSA_CannabisLinkedIn:<a href="https://www.linkedin.com/company/green-rush-comms/" rel="nofollow" target="_blank"> https://www.linkedin.com/company/green-rush-comms/</a>Facebook:<a href="https://www.facebook.com/KCSACannabiz/" rel="nofollow" target="_blank">https://www.facebook.com/KCSACannabiz/</a>YouTube:<a href="https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true" rel="nofollow" target="_blank"> https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true</a>

Dr. Oludare Odumosu, Chief Scientific Officer/EVP Pharmaceutical Division for Ilera Healthcare